hibleyytogoja1273.blogspot.com
million dollar settlement with in a case alleging that Amgen and 47 othed pharmaceutical companies defrauded the Kentucky Medicaid Program and violatedstate consumer-protection laws. The settlement, which was announced in a news releasdefrom Conway’s office, puts an end to Amgen’ds involvement in a lawsuit filed by the Office of the Attorney General in Frankli n Circuit Court. The settlement is not an admissiojn of liability inthe case, the releasde noted. Amgen, a California-based biotechnology and pharmaceuticak company, operates a distribution facilittyin Louisville.
The state claimed that Amgen and othetr drugcompanies “published significantlyh inflated average wholesale prices for prescription drugs, knowing that the Kentuckty Medicaid Program would rely on these inflated AWPs to calculate pharmach reimbursement rates,” the release “These inflated AWPs bore no relationshipp to any prices that Amgen actually chargedr its customers. Previously, the state reached settlement s withfor $145,000 and for $3 million, accordinb to Allison Martin, communication director for Conway’zs office. The funds will be returned to theMedicaifd program.
The federally funded which is managed bythe state, provides healtnh benefits for indigent patients. “I am pleased that we were able to recovert these funds for Kentucky taxpayers who are tired of some pharmaceutical companiees that try to increase profits by gaminhthe system,” Conway said in the release. “I appreciatwe Amgen’s cooperation in this
No comments:
Post a Comment